CARRIE MCADAM MARX portrait
  • Adjunct Associate Professor, Pharmacotherapy
801-587-7728

Presentations

  • Brixner DI, McAdam-Marx C, Van Den Bos J, Perlman D. Costs One Year Post Diagnosis for Alzheimer Patients and their Spouses vs. Matched Controls. 2010 American Geriatrics Society Annual Scientific Meeting May 13, 2010. Orlando, FL. Poster, Presented, 05/2010.
  • Brixner DI, McAdam-Marx C, Van Den Bos J, Perlman D. Resource Use for Caregivers vs. Matched Controls One-Year Pre vs. Post Patient Diagnosis for Alzheimer Disease. 2010 American Geriatrics Society Annual Scientific Meeting May 13, 2010. Orlando, FL. Poster, Presented, 05/2010.
  • Brixner DI, McAdam-Marx C, Van Den Bos J, Perlman D. Approach to Matching Patients with Alzheimer’s Disease and their Spouse to Control Patients in Spouses in an Administrative Claims Database. 15th Annual International Meeting International Society of Pharmacoeconomics and Outcomes Research (ISPOR). May 18, 2010. Atlanta, GA. Poster, Presented, 05/2010.
  • Late Phase Development of an Antidiabetic Treatment: A Case Study. Late Phase Drug Development World Americas 2010. March 26, 2010. Princeton, NJ. Presentation, Presented, 03/2010.

Languages

  • English, fluent.

Publications

  • Lin J, Jiao T, Biskupiak J, McAdam-Marx C. Application of Electronic Medical Record Data For Health Outcomes Research: A Review of Recent Literature. Expert Review of Pharmacoeconomics & Outcomes Research. 2013. Accepted for Publication. Accepted, 02/2013.
  • Jennings BT, Marx CM. Implementation of a pharmacist-managed diabetes program. Am J Health Syst Pharm. 2012 Nov 15;69(22):1951-3. PubMed PMID: 23135560. Published, 12/2012.
  • Kirkness CS, McAdam-Marx C, Unni S, Young J, Ye X, Chandran A, Peters CL, Asche CV. Characterization of patients undergoing total knee arthroplasty in a real-world setting and pain-related medication prescriptions for management ofpostoperative pain. J Pain Palliat Care Pharmacother. 2012 Dec;26(4):326-33. PubMed PMID: 23216171. Published, 12/2012.
  • Kirkness CS, McAdam-Marx C, Unni S, Young J, Ye X, Chandran A, Peters CL, Asche CV. Characterization of Patients Undergoing Total Hip Arthroplasty in a Real-World Setting and Pain-Related Medication Prescriptions for Management of Postoperative Pain. J Pain Palliat Care Pharmacother. 2012 Nov 19. PubMed PMID: 23163810. Published, 11/2012.
  • McAdam-Marx C, Joy E, Dahal A, Brixner D. A Retrospective Analysis of Follow-up Timing and Blood Pressure Outcomes after Initiation of Antihypertensive Therapy in Patients with Hypertension Treated in a Utah Community Setting. Accepted for publication, September, 2012. Utah Health 2012. Accepted, 07/2012.
  • McAdam-Marx C, Unni S, Ye X, Nelson S, Nickman NA. Effect of medicare reimbursement reduction for imaging services on osteoporosis screening rates. J Am Geriatr Soc. 2012. Mar;60(3):511-6. Published, 03/2012.
  • McAdam-Marx C, McGarry LJ, Hane CA, Biskupiak J, Deniz B, Brixner DI. All-Cause and Incremental Per Patient Per Year Cost Associated with Chronic Hepatitis C Virus and Associated Liver Complications in the United States: A Managed Care Perspective. J Manag Care Pharm. 2011. 17(7): 531-46. Published, 07/2011.
    http://www.amcp.org/JMCP/2011/September_2011/10723...
  • Nelson RE, McAdam-Marx C, Evans ML, Ward R, Campbell B, Brixner D, Lafleur J. Patent extension policy for paediatric indications: an evaluation of the impact within three drug classes in a state Medicaid programme. Appl Health Econ Health Policy. 2011 May 1;9(3):171-81. Published, 05/2011.
    http://adisonline.com/healtheconomics/pages/articl...
  • Bellows BK, Hunter E, McAdam-Marx C. Exenatide: Review of its Role as Adjunctive Therapy in Patients with Type 2 Diabetes. Clinical Medicine Reviews in Vascular Health. 2011:3. Libertas Academica. Published, 04/2011.
    http://www.la-press.com/exenatide-review-of-its-ro...
  • McAdam-Marx C, Bouchard J, Aagren M, Conner C, Brixner DI. Concurrent control of blood glucose, body mass, and blood pressure in patients with type 2 diabetes: an analysis of data from electronic medical records. Clin Ther. 2011 Jan;33(1):110-20. Published, 01/2011.
  • Munger MA, Shane-McWhorter L, McAdam-Marx C. Prediabetes: Implications for Managed Care. Am J Pharm Benefits. 2010;2(7): 429-441. Published, 12/2010.
  • Young JR, McAdam-Marx C. Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog. Clinical Medicine Insights: Endocrinology and Diabetes, Volume: 2010, Issue: 3 Libertas Academica. Published, 12/2010.
    http://www.la-press.com/treatment-of-type-1-and-ty...
  • Ghate S, Haroutiunian S, Winsow R, McAdam-Marx C. Cost and Comorbidities Associated with Opioid Abuse in Managed Care and Medicaid Patients in the United Stated: A Comparison of Two Recently Published Studies. J Pain Palliat Care Pharmacother; 2010; 24(3): 251-8. Published, 09/24/2010.
  • LaFleur J, McAdam-Marx C, Alder SS, Sheng X, Asche CV, Nebeker J Brixner DI, Silverman SL. Clinical risk factors for fracture among postmenopausal patients 3 at risk for fracture: a historical cohort study using electronic 4 medical record data. J Bone Miner Metab. 2010. Aug 6 (e-pub ahead of print). Published, 08/06/2010.
  • Brixner DI, McAdam-Marx C, Ye X, Lau H, Munger MA. Assessment of Time to Follow-up Visits in Newly-Treated Hypertensive Patients Using an Electronic Medical Record Database. Curr Med Res Opin. 2010; 26(8):1881-1891. Published, 08/2010.
  • McAdam-Marx C, Gaebler JA, Bellows BK, Brixner DI. Comprehensive Management of Patients with Type 2 Diabetes. Exp Rev Cardiovasc Health. 2010; 8(6):767-770. Published, 06/2010.
  • Said Q, McAdam Marx C, Schwartz SJ, Ben-Joseph R, Brixner DI. Impact of Body Mass Index on the Incidence of Cardiometabolic Risk Factors in Ambulatory Care Settings over Five Years or More. Value in Health, 2010; 13(2):265-272. Published, 02/2010.
  • McAdam-Marx C, Yu J, Bouchard J, Aagren M, Brixner DI. Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin. Curr Med Res Opin. 2010 Jan 26; (1):191-201. Published, 01/2010.
  • McAdam-Marx C, Field RT, Metraux S, Moelter ST, Brixner DI. Physician Utilization by Insurance Type in Youth with Type 2 Diabetes, Am J Manag Care. 2010; 16(1):55-64. Published, 01/2010.
  • McAdam-Marx C, Roland CL, Cleveland J, Oderda GM. Costs of Opioid Abuse and Misuse Determined from a Medicaid Database. J Pain Palliat Care Pharmacother. 2010; 24(1):5-18. Published, 01/2010.
  • McAdam-Marx C, Fabunmi R, Ye X, Boye KS, Nielsen LL, Wintle M, Misurski D, Brixner DI, A1C and Weight outcomes at 18 months in patients with type 2 diabetes treated with exenatide in an ambulatory care setting. Diabetes Obes Metab. 2009; 11(12):1173-4. Published, 2009.
  • Asche C, Nelson R, McAdam-Marx C, Jhaveri M, Ye X. Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. Osteoporos Int. 2009 Oct 2. [Epub ahead of print]. Published, 2009.
  • Brixner DI, McAdam-Marx C, Ye X, Boye KS, Nielsen LL, Wintle M, Misurski D, Fabunmi R. Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting. Diab Obes Met. 2009; 11(12):1122-30. Published, 2009.
  • McAdam-Marx C. Ye X; Sung JC, Brixner DI, Kahler KH. Results of a Retrospective, Observational Pilot Study Using Electronic Medical Records to Assess the Prevalence and Characteristics of Patients with Resistant Hypertension in an Ambulatory-Care Setting. Clin Ther. 2009; 31(5):1116-23. Published, 2009.
  • Holtorf AP, McAdam-Marx C, Schaaf D, Eng B, Oderda G. Systematic review on quality control for drug management programs: Is quality reported in the literature? BMC Health Serv Res. 2009; 9(1):38. Published, 2009.